Y-Biologics, Inc. (KOSDAQ:338840)
South Korea · Delayed Price · Currency is KRW 22,800
-900 (-3.80%)
At close: Feb 6, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 346.06 billion as of February 6, 2026. Its market cap has increased by 187.59% in one year.
Market Cap
346.06B
Enterprise Value
322.93B
Revenue
3.61B
Ranking
n/a
PE Ratio
n/a
Stock Price
22,800.00
Market Cap Chart
Since December 5, 2023, Y-Biologics's market cap has increased from 177.50B to 346.06B, an increase of 94.97%. That is a compound annual growth rate of 35.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 346.06B | -0.44% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
| Dec 5, 2023 | 177.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HansBiomed | 548.08B |
| ToolGen | 488.11B |
| S.Biomedics | 379.60B |
| GC Cell | 365.91B |
| NIBEC | 350.61B |
| ABION | 306.79B |
| Genome & Company | 262.77B |
| curacle co.,ltd. | 256.21B |